Indian drugmakers lobby to win Trump over on generic imports
Bloomberg India’s largest pharmaceutical firms are looking to convince US President Donald Trump that his promise to lower drug costs should take priority over his vow to make sure the medicines are made in America. The Indian Pharmaceutical Alliance, an industry group representing 20 of the nation’s largest drugmakers, is recommending India make the case to US lawmakers, regulators ...
Read More »